References
- Toth PP, Urtis J. Commonly used muscle relaxant therapies for acute low back pain: a review of carisoprodol, cyclobenzaprine hydrochloride, and metaxalone. ClinTher 2000; 26:1355–1367.
- Harden RN, Argoff C. A review of three commonly prescribed skeletal muscle relaxants. J Back MusculoskeletRehabil 2000; 15: 63–66.
- Moore KA, Levine B, Fowler D. A fatality involving metaxalone. Forensic Sci Int 2005; 149:249–251.
- Poklis JL, Ropero-Miller JD, Garside D, Winecker RE. Metaxalone (skelaxin®)-related death. J Anal Toxicol 2004; 28:537–541.
- Forrester MB. Adult metaxalone ingestions reported to texas poison control centers, 2000–2006. Hum ExpToxicol 2010; 29:55–62.
- Bosak AR, Skolnik AB. Serotonin syndrome associated with metaxalone overdose. J Med Toxicol. 2014 epub ahead of print, DOI 10.1007/s13181-014-0404-5.
- Igneri L, Shaw C, Solomon B. Life-threatening serotonin syndrome after administration of metaxalone in a patient on citalopram. Crit Care Med 2013; 41:A285.
- Baselt, Randall C. Disposition of Toxic Drugs and Chemicals in Man. 10th Edition. Seal Beach: Biomedical Publications, CA. 2014. pp. 1254–1255.
- Lintner CP, Topeff JM, Katzung KG, Kwon SK, Cole JB, Orozco BS. Non-expected metaxalone symptoms. ClinToxicol 2013; 51: 674–675.
- Quinn DK, Stern TA. Linezolid and serotonin syndrome. Prim Care Companion J Clin Psychiatry 2009; 11:353–356.
- Huang V, Gortney JS. Risk of serotonin syndrome with concomitant administration of linezolid and serotonin agonists. Pharmacotherapy 2006; 26:1784–1793.
- Gillman KP. CNS toxicity involving methylene blue: the exemplar for understanding and predicting drug interactions that precipitate serotonin toxicity. J Psychopharmacol 2010; 25:429–436.
- Dunkley EJ, Isbister GK, Sibbritt D, Dawson AH, Whyte IM. The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity. QJM 2003; 96:635–642.